HKU scientists and microbiologists jointly discover a novel antiviral strategy for treatment of COVID-19 using existing metallodrugs
Abstract
A research team led by Professor Hongzhe SUN and Professor Kwok Yung YUEN at the University of Hong Kong (HKU) has discovered a new antiviral strategy for the treatment of COVID-19. They found that a class of metallodrugs, currently used in the treatment of other infectious diseases, can effectively suppress SARS-CoV-2 replication and relieve viral-associated symptoms in an animal model. The findings offer a new and readily available therapeutic option with high clinical potential.
Resource Type
Addition Details
Date:
2020-10-12
Category:
Source URL:
Share